NanoNewron
@nanonewron.bsky.social
NanoNewron is a biotech company developing a novel treatment for Alzheimer’s and other neurodegenerative diseases.
Pinned
NanoNewron
@nanonewron.bsky.social
· Mar 5
At NanoNewron, we develop biologics that cross the blood-brain barrier to neutralize TNF-α, a key driver of neuroinflammation in Alzheimer’s & neurodegeneration. Our TfR1-mediated transcytosis platform enables targeted TNF-α inhibition to restore brain health.
#NanoNewron #newrobus #biotech
#NanoNewron #newrobus #biotech
🧠We are hiring! PhD candidates defending soon or recent grads! Bring your expertise to cutting-edge neuroscience & biotech research! Learn more here: www.linkedin.com/posts/bahar-...
FY26-001_NGO-Innovation Research Fellowship Program-IRFP.pdf | Bahar Aksoy
We’re Hiring!
NanoNewron is excited to announce an opportunity for a Ph.D. Research Fellow through the NJ Department of Labor’s Innovation and Research Fellowship Program (IRFP).
This grant-funded rol...
www.linkedin.com
September 24, 2025 at 1:34 PM
🧠We are hiring! PhD candidates defending soon or recent grads! Bring your expertise to cutting-edge neuroscience & biotech research! Learn more here: www.linkedin.com/posts/bahar-...
Today is #WorldAlzheimersDay 💜
We honor the millions of families impacted by this disease.
At NanoNewron, we’re advancing breakthrough therapies to bring hope and transform the future of Alzheimer’s care.
#EndAlz #TogetherForAlzheimers #BiotechForGood
We honor the millions of families impacted by this disease.
At NanoNewron, we’re advancing breakthrough therapies to bring hope and transform the future of Alzheimer’s care.
#EndAlz #TogetherForAlzheimers #BiotechForGood
September 21, 2025 at 5:53 PM
Today is #WorldAlzheimersDay 💜
We honor the millions of families impacted by this disease.
At NanoNewron, we’re advancing breakthrough therapies to bring hope and transform the future of Alzheimer’s care.
#EndAlz #TogetherForAlzheimers #BiotechForGood
We honor the millions of families impacted by this disease.
At NanoNewron, we’re advancing breakthrough therapies to bring hope and transform the future of Alzheimer’s care.
#EndAlz #TogetherForAlzheimers #BiotechForGood
🧠✨Excited to announce that NanoNewron has secured a $2.5 million NIH STTR Phase 2 grant to advance our Alzheimer’s disease program!
IND submission expected next year.
More info: www.globenewswire.com/news-release...
#Alzheimers #NIH #Biotech #NanoNewron #NIHGrant
IND submission expected next year.
More info: www.globenewswire.com/news-release...
#Alzheimers #NIH #Biotech #NanoNewron #NIHGrant
September 10, 2025 at 2:24 PM
🧠✨Excited to announce that NanoNewron has secured a $2.5 million NIH STTR Phase 2 grant to advance our Alzheimer’s disease program!
IND submission expected next year.
More info: www.globenewswire.com/news-release...
#Alzheimers #NIH #Biotech #NanoNewron #NIHGrant
IND submission expected next year.
More info: www.globenewswire.com/news-release...
#Alzheimers #NIH #Biotech #NanoNewron #NIHGrant
From insightful meetings to spontaneous hallway conversations — BIO2025 is full of energy and ideas.
Here’s our CEO, Dr. Marco Taglietti capturing the spirit of collaboration.
#BIO2025 #LeadershipInBiotech #NanoNewron
Here’s our CEO, Dr. Marco Taglietti capturing the spirit of collaboration.
#BIO2025 #LeadershipInBiotech #NanoNewron
June 17, 2025 at 6:39 PM
From insightful meetings to spontaneous hallway conversations — BIO2025 is full of energy and ideas.
Here’s our CEO, Dr. Marco Taglietti capturing the spirit of collaboration.
#BIO2025 #LeadershipInBiotech #NanoNewron
Here’s our CEO, Dr. Marco Taglietti capturing the spirit of collaboration.
#BIO2025 #LeadershipInBiotech #NanoNewron
We’re excited to share that NanoNewron will be at BIO 2025 in Boston!
Our CEO, Dr. Marco Taglietti, will be attending and looks forward to connecting with fellow biotech leaders, potential partners, and investors.
#BIO2025 #Biotech #LifeSciences #Innovation #Partnering
Our CEO, Dr. Marco Taglietti, will be attending and looks forward to connecting with fellow biotech leaders, potential partners, and investors.
#BIO2025 #Biotech #LifeSciences #Innovation #Partnering
June 16, 2025 at 3:10 AM
We’re excited to share that NanoNewron will be at BIO 2025 in Boston!
Our CEO, Dr. Marco Taglietti, will be attending and looks forward to connecting with fellow biotech leaders, potential partners, and investors.
#BIO2025 #Biotech #LifeSciences #Innovation #Partnering
Our CEO, Dr. Marco Taglietti, will be attending and looks forward to connecting with fellow biotech leaders, potential partners, and investors.
#BIO2025 #Biotech #LifeSciences #Innovation #Partnering
Rethinking Alzheimer’s Risk Factors. If inflammation drives neurodegeneration, could TNFα inhibitors slow or prevent Alzheimer’s? The evidence is growing, and the implications are huge. 🚀
#NanoNewron #AlzheimersResearch #Neurodegeneration #BrainHealth
#Neuroscience #Inflammation
#NanoNewron #AlzheimersResearch #Neurodegeneration #BrainHealth
#Neuroscience #Inflammation
May 30, 2025 at 3:20 PM
Rethinking Alzheimer’s Risk Factors. If inflammation drives neurodegeneration, could TNFα inhibitors slow or prevent Alzheimer’s? The evidence is growing, and the implications are huge. 🚀
#NanoNewron #AlzheimersResearch #Neurodegeneration #BrainHealth
#Neuroscience #Inflammation
#NanoNewron #AlzheimersResearch #Neurodegeneration #BrainHealth
#Neuroscience #Inflammation
Rutgers & NanoNewron have developed fully humanized camelid nanobodies that potently neutralize TNFα—a key driver of neuroinflammation & autoimmune disease.
Compact. Stable. Human-specific.
Next-gen therapies are here.
🔗 www.tandfonline.com/doi/full/10....
#Biotech @rutgersresearch.bsky.social
Compact. Stable. Human-specific.
Next-gen therapies are here.
🔗 www.tandfonline.com/doi/full/10....
#Biotech @rutgersresearch.bsky.social
Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases
Tumor necrosis factor-alpha (TNFα) is a key pro-inflammatory cytokine implicated in the pathogenesis of numerous inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory b...
www.tandfonline.com
May 14, 2025 at 6:46 PM
Rutgers & NanoNewron have developed fully humanized camelid nanobodies that potently neutralize TNFα—a key driver of neuroinflammation & autoimmune disease.
Compact. Stable. Human-specific.
Next-gen therapies are here.
🔗 www.tandfonline.com/doi/full/10....
#Biotech @rutgersresearch.bsky.social
Compact. Stable. Human-specific.
Next-gen therapies are here.
🔗 www.tandfonline.com/doi/full/10....
#Biotech @rutgersresearch.bsky.social
We’re looking forward to celebrating New Jersey’s top innovation leaders, including our CEO, Marco Taglietti at the Innovate100 event on May 13.
Learn more and join the celebration at innovatenewjersey.com
#Innovate100
#Innovation #Leadership #Biotech #NewJersey
Learn more and join the celebration at innovatenewjersey.com
#Innovate100
#Innovation #Leadership #Biotech #NewJersey
May 5, 2025 at 8:03 PM
We’re looking forward to celebrating New Jersey’s top innovation leaders, including our CEO, Marco Taglietti at the Innovate100 event on May 13.
Learn more and join the celebration at innovatenewjersey.com
#Innovate100
#Innovation #Leadership #Biotech #NewJersey
Learn more and join the celebration at innovatenewjersey.com
#Innovate100
#Innovation #Leadership #Biotech #NewJersey
The Future of Brain Medicine is Here 🚀🧬
What if biologics could reach the exact brain regions they’re needed in? Our highly specific, BBB-permeable platform makes targeted treatment a reality. #NanoNewron #BrainHealth #NeuroScience #Biotech
#MedicalInnovation #FutureOfMedicine
What if biologics could reach the exact brain regions they’re needed in? Our highly specific, BBB-permeable platform makes targeted treatment a reality. #NanoNewron #BrainHealth #NeuroScience #Biotech
#MedicalInnovation #FutureOfMedicine
May 1, 2025 at 3:39 PM
The Future of Brain Medicine is Here 🚀🧬
What if biologics could reach the exact brain regions they’re needed in? Our highly specific, BBB-permeable platform makes targeted treatment a reality. #NanoNewron #BrainHealth #NeuroScience #Biotech
#MedicalInnovation #FutureOfMedicine
What if biologics could reach the exact brain regions they’re needed in? Our highly specific, BBB-permeable platform makes targeted treatment a reality. #NanoNewron #BrainHealth #NeuroScience #Biotech
#MedicalInnovation #FutureOfMedicine
Double helix, big impact.🧬
Happy National DNA Day to the molecule that started it all.
#NationalDNADay #DNA #Genetics #Biotech #neuroscience #NanoNewron
Happy National DNA Day to the molecule that started it all.
#NationalDNADay #DNA #Genetics #Biotech #neuroscience #NanoNewron
April 25, 2025 at 12:45 PM
Double helix, big impact.🧬
Happy National DNA Day to the molecule that started it all.
#NationalDNADay #DNA #Genetics #Biotech #neuroscience #NanoNewron
Happy National DNA Day to the molecule that started it all.
#NationalDNADay #DNA #Genetics #Biotech #neuroscience #NanoNewron
We’re excited to share that our CEO will be taking the stage at the HELIX DISCOVERY SHOWCASE on April 29, 2025 to present NanoNewron — our bold step forward in biotech innovation.
Come see what the future looks like.
#HELIX2025 #nanonewron
Come see what the future looks like.
#HELIX2025 #nanonewron
April 18, 2025 at 4:44 PM
We’re excited to share that our CEO will be taking the stage at the HELIX DISCOVERY SHOWCASE on April 29, 2025 to present NanoNewron — our bold step forward in biotech innovation.
Come see what the future looks like.
#HELIX2025 #nanonewron
Come see what the future looks like.
#HELIX2025 #nanonewron
Hope on the Horizon for Alzheimer’s Patients 💙
Imagine a future where effective treatments for neurodegeneration are no longer hindered by the Blood-Brain Barrier. With our TfR1-based biologic delivery platform, NewroBus™, that future is closer than ever. #AlzheimersResearch #NanoNewron
Imagine a future where effective treatments for neurodegeneration are no longer hindered by the Blood-Brain Barrier. With our TfR1-based biologic delivery platform, NewroBus™, that future is closer than ever. #AlzheimersResearch #NanoNewron
April 15, 2025 at 3:01 PM
Hope on the Horizon for Alzheimer’s Patients 💙
Imagine a future where effective treatments for neurodegeneration are no longer hindered by the Blood-Brain Barrier. With our TfR1-based biologic delivery platform, NewroBus™, that future is closer than ever. #AlzheimersResearch #NanoNewron
Imagine a future where effective treatments for neurodegeneration are no longer hindered by the Blood-Brain Barrier. With our TfR1-based biologic delivery platform, NewroBus™, that future is closer than ever. #AlzheimersResearch #NanoNewron
TNFα: Friend or Foe? While TNFα plays a key role in immune defense, chronic inflammation is linked to neurodegeneration. New studies suggest blocking TNFα could help reduce Alzheimer’s risk. Could this be a breakthrough in prevention? 🔬🧪
#NanoNewron #Neuroscience #AlzheimersResearch #TNFalpha
#NanoNewron #Neuroscience #AlzheimersResearch #TNFalpha
April 14, 2025 at 1:24 PM
TNFα: Friend or Foe? While TNFα plays a key role in immune defense, chronic inflammation is linked to neurodegeneration. New studies suggest blocking TNFα could help reduce Alzheimer’s risk. Could this be a breakthrough in prevention? 🔬🧪
#NanoNewron #Neuroscience #AlzheimersResearch #TNFalpha
#NanoNewron #Neuroscience #AlzheimersResearch #TNFalpha
Brain Inflammation and Memory Loss-What’s the Link? Chronic inflammation has long been suspected in Alzheimer’s disease. Now, TNFα inhibitors show promise in reducing this risk. Are we on the verge of a game-changing discovery? 🚀
#NanoNewron #Neuroscience
#AlzheimersResearch #BrainHealth
#NanoNewron #Neuroscience
#AlzheimersResearch #BrainHealth
April 11, 2025 at 1:46 PM
Brain Inflammation and Memory Loss-What’s the Link? Chronic inflammation has long been suspected in Alzheimer’s disease. Now, TNFα inhibitors show promise in reducing this risk. Are we on the verge of a game-changing discovery? 🚀
#NanoNewron #Neuroscience
#AlzheimersResearch #BrainHealth
#NanoNewron #Neuroscience
#AlzheimersResearch #BrainHealth
The BBB Problem: Solved. ✅🧠
The Blood-Brain Barrier is one of the biggest challenges in neurology. Our patented TfR1-based transcytosis platform efficiently transports biologics where they’re needed, without compromising safety or specificity. #FutureOfMedicine
#Neuroscience
The Blood-Brain Barrier is one of the biggest challenges in neurology. Our patented TfR1-based transcytosis platform efficiently transports biologics where they’re needed, without compromising safety or specificity. #FutureOfMedicine
#Neuroscience
April 10, 2025 at 12:56 PM
The BBB Problem: Solved. ✅🧠
The Blood-Brain Barrier is one of the biggest challenges in neurology. Our patented TfR1-based transcytosis platform efficiently transports biologics where they’re needed, without compromising safety or specificity. #FutureOfMedicine
#Neuroscience
The Blood-Brain Barrier is one of the biggest challenges in neurology. Our patented TfR1-based transcytosis platform efficiently transports biologics where they’re needed, without compromising safety or specificity. #FutureOfMedicine
#Neuroscience
TNFα and Alzheimer’s—The Science is Clear
Inflammation is a key driver of neurodegeneration, and TNFα inhibitors show promise in lowering Alzheimer’s risk. Is it time to rethink how we approach brain aging? 🧠⏳
#AlzheimersAwareness #BrainHealth #Neuroinflammation #TNFalpha
Inflammation is a key driver of neurodegeneration, and TNFα inhibitors show promise in lowering Alzheimer’s risk. Is it time to rethink how we approach brain aging? 🧠⏳
#AlzheimersAwareness #BrainHealth #Neuroinflammation #TNFalpha
April 9, 2025 at 12:37 PM
TNFα and Alzheimer’s—The Science is Clear
Inflammation is a key driver of neurodegeneration, and TNFα inhibitors show promise in lowering Alzheimer’s risk. Is it time to rethink how we approach brain aging? 🧠⏳
#AlzheimersAwareness #BrainHealth #Neuroinflammation #TNFalpha
Inflammation is a key driver of neurodegeneration, and TNFα inhibitors show promise in lowering Alzheimer’s risk. Is it time to rethink how we approach brain aging? 🧠⏳
#AlzheimersAwareness #BrainHealth #Neuroinflammation #TNFalpha
🌍 World Health Day 🌍
Innovating today for a healthier tomorrow.
Biotechnology is driving breakthroughs in medicine, sustainability, and global health. Let’s continue pushing boundaries to build a future where health is truly for all.
#WorldHealthDay #Biotech #HealthForAll
Innovating today for a healthier tomorrow.
Biotechnology is driving breakthroughs in medicine, sustainability, and global health. Let’s continue pushing boundaries to build a future where health is truly for all.
#WorldHealthDay #Biotech #HealthForAll
April 7, 2025 at 2:50 PM
🌍 World Health Day 🌍
Innovating today for a healthier tomorrow.
Biotechnology is driving breakthroughs in medicine, sustainability, and global health. Let’s continue pushing boundaries to build a future where health is truly for all.
#WorldHealthDay #Biotech #HealthForAll
Innovating today for a healthier tomorrow.
Biotechnology is driving breakthroughs in medicine, sustainability, and global health. Let’s continue pushing boundaries to build a future where health is truly for all.
#WorldHealthDay #Biotech #HealthForAll
Crossing the Uncrossable: The BBB 🌉
Traditional drugs fail to reach the brain due to the Blood-Brain Barrier. Our NewroBus™ platform efficiently and safely delivers biologics across this barrier—bringing new hope for patients with Alzheimer’s, ALS, and more. #BiotechInnovation
Traditional drugs fail to reach the brain due to the Blood-Brain Barrier. Our NewroBus™ platform efficiently and safely delivers biologics across this barrier—bringing new hope for patients with Alzheimer’s, ALS, and more. #BiotechInnovation
April 4, 2025 at 2:13 PM
Crossing the Uncrossable: The BBB 🌉
Traditional drugs fail to reach the brain due to the Blood-Brain Barrier. Our NewroBus™ platform efficiently and safely delivers biologics across this barrier—bringing new hope for patients with Alzheimer’s, ALS, and more. #BiotechInnovation
Traditional drugs fail to reach the brain due to the Blood-Brain Barrier. Our NewroBus™ platform efficiently and safely delivers biologics across this barrier—bringing new hope for patients with Alzheimer’s, ALS, and more. #BiotechInnovation
Today, we honor the dedication, compassion, and innovation of doctors who work tirelessly to improve lives. Your expertise and commitment drive progress in medicine and global health. Thank you for making a difference!
#DoctorsDay #HealthcareHeroes #MedicalInnovation #MedicineMatters
#DoctorsDay #HealthcareHeroes #MedicalInnovation #MedicineMatters
March 30, 2025 at 5:39 PM
Today, we honor the dedication, compassion, and innovation of doctors who work tirelessly to improve lives. Your expertise and commitment drive progress in medicine and global health. Thank you for making a difference!
#DoctorsDay #HealthcareHeroes #MedicalInnovation #MedicineMatters
#DoctorsDay #HealthcareHeroes #MedicalInnovation #MedicineMatters
Thrilled to share that our CEO, Dr. Marco Taglietti, has been named one of New Jersey’s Innovate100 Leaders by NJ Business Magazine! 🌟 Congratulations to Dr. Taglietti and all the honorees driving innovation forward! 🏆 Read more: njbmagazine.com/njb-news-now... #Innovation #Leadership
NJ’s Innovate100 Leaders to Be Honored May 13
On May 13, the INNOVATE100 leaders from across the state will be honored and celebrated in New Brunswick.
njbmagazine.com
March 25, 2025 at 5:43 PM
Thrilled to share that our CEO, Dr. Marco Taglietti, has been named one of New Jersey’s Innovate100 Leaders by NJ Business Magazine! 🌟 Congratulations to Dr. Taglietti and all the honorees driving innovation forward! 🏆 Read more: njbmagazine.com/njb-news-now... #Innovation #Leadership
In @elife.bsky.social : Microglia TREM2R47H Alzheimer-linked variant enhances excitatory transmission and reduces LTP via increased TNF-α levels
doi.org/10.7554/eLif...
#AlzheimersResearch #Neuroscience #DementiaRisk #TREM2 #Microglia #BrainHealth
doi.org/10.7554/eLif...
#AlzheimersResearch #Neuroscience #DementiaRisk #TREM2 #Microglia #BrainHealth
Microglia TREM2R47H Alzheimer-linked variant enhances excitatory transmission and reduces LTP via increased TNF-α levels
Analysis of rats carrying the microglia gene and Alzheimer risk factor Trem2R47H variant shows increased glutamatergic transmission via supraphysiological TNF-α brain concentrations, linking a microgl...
doi.org
March 18, 2025 at 1:42 PM
In @elife.bsky.social : Microglia TREM2R47H Alzheimer-linked variant enhances excitatory transmission and reduces LTP via increased TNF-α levels
doi.org/10.7554/eLif...
#AlzheimersResearch #Neuroscience #DementiaRisk #TREM2 #Microglia #BrainHealth
doi.org/10.7554/eLif...
#AlzheimersResearch #Neuroscience #DementiaRisk #TREM2 #Microglia #BrainHealth
TNF-α–mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer’s disease pathology in young Trem2R47H rats - Journal of Biological Chemistry www.jbc.org/article/S002...
#AlzheimersResearch #Neuroscience #BrainHealth #Neurodegeneration
#AlzheimersResearch #Neuroscience #BrainHealth #Neurodegeneration
TNF-α–mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer’s disease pathology in young Trem2R47H rats
Alzheimer’s disease (AD) is a neurodegenerative dementia associated with deposition
of amyloid plaques and neurofibrillary tangles, formed by amyloid β (Aβ) peptides
and phosphor-tau, respectively, in...
www.jbc.org
March 17, 2025 at 2:51 PM
TNF-α–mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer’s disease pathology in young Trem2R47H rats - Journal of Biological Chemistry www.jbc.org/article/S002...
#AlzheimersResearch #Neuroscience #BrainHealth #Neurodegeneration
#AlzheimersResearch #Neuroscience #BrainHealth #Neurodegeneration
research.rutgers.edu/news/rutgers...
#nanonewron #newrobus #alzheimers #research #biologics #biotech #brainhealth
#nanonewron #newrobus #alzheimers #research #biologics #biotech #brainhealth
Rutgers Startup Hopes Its Potentially Breakthrough Technology Will Improve Alzheimer’s Treatment
NanoNewron, Inc., a startup founded based on technology developed at Rutgers, The State University of New Jersey, looks to advance its potentially game changing approach towards treating Alzheimer’s D...
research.rutgers.edu
March 8, 2025 at 7:28 PM
www.globenewswire.com/news-release...
#nanonewron #newrobus #alzheimer’s #biotech #research #biologics #bloodbrainbarrier #brainhealth
#nanonewron #newrobus #alzheimer’s #biotech #research #biologics #bloodbrainbarrier #brainhealth
NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound
Marco Taglietti, MD is appointed CEO of NanoNewron, a company developing TNF-α inhibitors for Alzheimer’s, engineered to cross the Blood-Brain Barrier...
www.globenewswire.com
March 5, 2025 at 7:35 PM